TAO Kinase 2 Antikörper (AA 719-880) (FITC)

Produktnummer ABIN7169193

Produktdetails anti-TAO Kinase 2 Antikörper (FITC)

Target: TAO Kinase 2 (TAOK2)

Bindungsspezifität: AA 719-880

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TAO Kinase 2 Antikörper ist konjugiert mit FITC

Applikation: Bitte anfragen

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Serine/threonine-protein kinase TAO2 protein (719-880AA)

Isotyp: IgG

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu TAO Kinase 2

Target: TAO Kinase 2 (TAOK2)

Andere Bezeichnung: TAOK2 (TAOK2 Produkte)

Synonyme: MAP3K17 antikoerper, PSK antikoerper, PSK1 antikoerper, PSK1-BETA antikoerper, TAO1 antikoerper, TAO2 antikoerper, Tao2 antikoerper, 1110033K02Rik antikoerper, B230344N16 antikoerper, mKIAA0881 antikoerper, TAOK2 antikoerper, map3k17 antikoerper, psk antikoerper, psk1 antikoerper, tao1 antikoerper, tao2 antikoerper, TAO kinase 2 antikoerper, TAO kinase 2 L homeolog antikoerper, serine/threonine-protein kinase TAO2 antikoerper, TAOK2 antikoerper, Taok2 antikoerper, taok2.L antikoerper, taok2 antikoerper, LOC100085396 antikoerper

Hintergrund:

Background: Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Isoform 1, but not isoform 2, plays a role in apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation. This function, which requires the activation of MAPK8/JNK and nuclear localization of C-terminally truncated isoform 1, may be linked to the mitochondrial CASP9-associated death pathway. Isoform 1 binds to microtubules and affects their organization and stability independently of its kinase activity. Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B activation, but not that of MAPK8/JNK. May play a role in the osmotic stress-MAPK8 pathway. Isoform 2, but not isoform 1, is required for PCDH8 endocytosis. Following homophilic interactions between PCDH8 extracellular domains, isoform 2 phosphorylates and activates MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms are involved in MAPK14 phosphorylation.

Aliases: 1110033K02Rik antibody, B230344N16 antibody, hKFC C antibody, hKFC-C antibody, KIAA0881 antibody, Kinase from chicken homolog C antibody, MAP3K17 antibody, mKIAA0881 antibody, Prostate derived STE20 like kinase 1 antibody, Prostate derived STE20 like kinase PSK antibody, Prostate derived sterile 20 like kinase 1 antibody, Prostate-derived STE20-like kinase 1 antibody, PSK 1 antibody, PSK antibody, PSK-1 antibody, PSK1 antibody, PSK1 beta antibody, Serine/threonine protein kinase TAO2 antibody, Serine/threonine-protein kinase TAO2 antibody, TAO 1 antibody, TAO 2 antibody, TAO kinase 2 antibody, TAO1 antibody, TAO2 antibody, TAOK 2 antibody, Taok2 antibody, TAOK2_HUMAN antibody, Thousand and one amino acid protein 2 antibody, Thousand and one amino acid protein kinase antibody, UNQ2971/PRO7431 antibody

UniProt: Q9UL54

Pathways: Cell-Cell Junction Organization